## Abstract The actions of 17β‐estradiol (E2) and selective estrogen receptor modulators (SERMs) have been extensively investigated regarding their ability to act through estrogen receptor‐α (ERα) to perturb estrogen receptor positive (ER+) breast cancer (BC) growth. However, many BCs also express
Estrogen modulates estrogen receptor α and β expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice
✍ Scribed by Shuanhu Zhou; Yoram Zilberman; Karsten Wassermann; Steven D. Bain; Yoel Sadovsky; Dan Gazit
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 257 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0730-2312
- DOI
- 10.1002/jcb.1096
No coin nor oath required. For personal study only.
✦ Synopsis
In the mouse, ovariectomy (OVX) leads to signi®cant reductions in cancellous bone volume while estrogen (17b-estradiol, E2) replacement not only prevents bone loss but can increase bone formation. As the E2dependent increase in bone formation would require the proliferation and differentiation of osteoblast precursors, we hypothesized that E2 regulates mesenchymal stem cells (MSCs) activity in mouse bone marrow. We therefore investigated proliferation, differentiation, apoptosis, and estrogen receptor (ER) a and b expression of primary culture MSCs isolated from OVX and sham-operated mice. MSCs, treated in vitro with 10 À7 M E2, displayed a signi®cant increase in ERa mRNA and protein expression as well as alkaline phosphatase (ALP) activity and proliferation rate. In contrast, E2 treatment resulted in a decrease in ERb mRNA and protein expression as well as apoptosis in both OVX and sham mice. E2 up-regulated the mRNA expression of osteogenic genes for ALP, collagen I, TGF-b1, BMP-2, and cbfa1 in MSCs. In a comparison of the relative mRNA expression and protein levels for two ER isoforms, ERa was the predominant form expressed in MSCs obtained from both OVX and sham-operated mice. Cumulatively, these results indicate that estrogen in vitro directly augments the proliferation and differentiation, ERa expression, osteogenic gene expression and, inhibits apoptosis and ERb expression in MSCs obtained from OVX and sham-operated mice. Coexpression of ERa, but not ERb, and osteogenic differentiation markers might indicate that ERa function as an activator and ERb function as a repressor in the osteogenic differentiation in MSCs. These results suggest that mouse MSCs are anabolic targets of estrogen action, via ERa activation.
📜 SIMILAR VOLUMES